This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
NOV Q2 Earnings Miss, Revenues Beat Estimates, Both Decrease Y/Y
by Zacks Equity Research
NOV expects a 1-3% decrease in consolidated revenues year over year for third-quarter 2025, with adjusted EBITDA anticipated to range from $230-$250 million.
Here's What Key Metrics Tell Us About Nov Inc. (NOV) Q2 Earnings
by Zacks Equity Research
The headline numbers for Nov Inc. (NOV) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nov Inc. (NOV) Q2 Earnings Miss Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of -3.33% and +1.85%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Oil States International (OIS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Oil States International (OIS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Factors You Need to Know Ahead of NOV's Q2 Earnings Release
by Zacks Equity Research
NOV is anticipated to report lower revenues from the year-ago period's level. Moreover, its increased cost of goods sold may further affect the bottom line.
Earnings Preview: Nov Inc. (NOV) Q2 Earnings Expected to Decline
by Zacks Equity Research
Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NOV Stock Down 24% in a Year: Should Investors Hold or Move On?
by Zacks Equity Research
NOV stock's sharp 24% slide reflects mounting headwinds from tariffs, weak demand and rising corporate costs.
Why Is USA Compression (USAC) Up 12.3% Since Last Earnings Report?
by Zacks Equity Research
USA Compression (USAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Nov Inc. (NOV) Up 2.5% Since Last Earnings Report?
by Zacks Equity Research
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is First Trust Energy AlphaDEX ETF (FXN) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXN
Should You Invest in the First Trust Energy AlphaDEX ETF (FXN)?
by Zacks Equity Research
Sector ETF report for FXN
NOV's Q1 Earnings Miss Estimates, Revenues Decrease Y/Y
by Zacks Equity Research
NOV expects revenues to decrease 1% to 4% year over year, with adjusted EBITDA between $250 million and $280 million for the second quarter of 2025.
Nov Inc. (NOV) Lags Q1 Earnings Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of -24% and 0.21%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Factors You Need to Know Ahead of NOV's Q1 Earnings Release
by Zacks Equity Research
NOV is anticipated to report lower revenues from the year-ago period's level. However, it is expected to record a higher bottom line thanks to reduced costs.
Earnings Preview: Nov Inc. (NOV) Q1 Earnings Expected to Decline
by Zacks Equity Research
Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Solaris Energy Infrastructure for Growth & Innovation?
by Zacks Equity Research
SEI is aggressively expanding into renewable energy, particularly in grid modernization and battery storage.
NOV & Petrobras Collaborate to Develop CO2-Resistant Flexible Pipes
by Zacks Equity Research
NOV mentions that the new technology will help combat SCC, which affects oil and gas subsea infrastructure. It also aims to retain the core features of standard flexible pipes.
Here's Why Retaining NOV Stock Makes Sense in the Current Market
by Zacks Equity Research
NOV's robust cash flow and growing backlog position it well, but risks from declining demand and commodity price fluctuations may impact growth.
Zacks Market Edge Highlights: Tesla, NVIDIA, JPMorgan Chase, Exxon Mobil and Novo Nordisk
by Zacks Equity Research
Tesla, NVIDIA, JPMorgan Chase, Exxon Mobil and Novo Nordisk are part of the Zacks Market Edge blog.
Is A Recession Coming in 2025? Where to Invest Now
by Tracey Ryniec
Tracey Ryniec and Zacks Chief Equity Strategist, John Blank, discuss the state of the economy and what stocks to invest in after the stock sell-off.
Is First Trust Energy AlphaDEX ETF (FXN) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXN
Nov Inc. (NOV) Down 13.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in the First Trust Energy AlphaDEX ETF (FXN)?
by Zacks Equity Research
Sector ETF report for FXN
NOV Q4 Earnings Surpass Estimates, Revenues Decrease Y/Y
by Zacks Equity Research
NOV expects a 1-3% year-over-year decline in revenues and adjusted EBITDA between $235 million and $265 million for first-quarter 2025.
Nov Inc. (NOV) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Nov Inc. (NOV) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.